Sat, Nov 22, 2014, 10:44 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • zwerp2000 zwerp2000 May 9, 2013 12:22 PM Flag

    Piper out with a note

    In a note to investors, Piper Jaffray analyst Edward Tenthoff wrote that he continues to believe that the FDA's request for more information on eteplirsen indicates that the agency is looking to facilitate accelerated approval of the drug. The analyst thinks that the FDA's request increased the chances of the drug being approved by the end of the year and he kept an Overweight rating on Sarepta

15.73-0.05(-0.32%)Nov 21 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Hexcel Corp.
NYSEFri, Nov 21, 2014 4:02 PM EST
XOMA Corporation
NasdaqGMFri, Nov 21, 2014 4:00 PM EST
NCR Corp.
NYSEFri, Nov 21, 2014 4:05 PM EST